154 related articles for article (PubMed ID: 2468622)
21. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
Wells E; Harper ST; Jackson CG; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
[TBL] [Abstract][Full Text] [Related]
22. Human heart mast cells: a definitive case of mast cell heterogeneity.
Patella V; de Crescenzo G; Ciccarelli A; Marinò I; Adt M; Marone G
Int Arch Allergy Immunol; 1995 Apr; 106(4):386-93. PubMed ID: 7536502
[TBL] [Abstract][Full Text] [Related]
23. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
24. The human skin mast cell.
Benyon RC
Clin Exp Allergy; 1989 Jul; 19(4):375-87. PubMed ID: 2667702
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of FK-506 on human skin mast cells.
de Paulis A; Stellato C; Cirillo R; Ciccarelli A; Oriente A; Marone G
J Invest Dermatol; 1992 Dec; 99(6):723-8. PubMed ID: 1281861
[TBL] [Abstract][Full Text] [Related]
26. [Neuropeptides and inflammation: presumed mechanisms in neurogenic inflammation].
Landry Y; Bloch JG; Mousli M; Bueb JL; Bronner C
Pathol Biol (Paris); 1990 Jan; 38(1):53-6. PubMed ID: 1689813
[TBL] [Abstract][Full Text] [Related]
27. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
28. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides.
Levi-Schaffer F; Shalit M
Int Arch Allergy Appl Immunol; 1989; 90(4):352-7. PubMed ID: 2482257
[TBL] [Abstract][Full Text] [Related]
29. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells.
Robinson C; Benyon C; Holgate ST; Church MK
J Invest Dermatol; 1989 Sep; 93(3):397-404. PubMed ID: 2504819
[TBL] [Abstract][Full Text] [Related]
30. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Wells E; Jackson CG; Harper ST; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of human mast cells and basophils. Effects of a putative 5-lipoxygenase inhibitor.
Cohan V; McKenzie-White J; Triggiani M; Massey W; Kagey-Sobotka A; Lichtenstein LM
Biochem Pharmacol; 1989 Dec; 38(24):4455-9. PubMed ID: 2481451
[TBL] [Abstract][Full Text] [Related]
32. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.
Bischoff SC; Schwengberg S; Lorentz A; Manns MP; Bektas H; Sann H; Levi-Schaffer F; Shanahan F; Schemann M
Neurogastroenterol Motil; 2004 Apr; 16(2):185-93. PubMed ID: 15086872
[TBL] [Abstract][Full Text] [Related]
33. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
34. On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin.
Piotrowski W; Foreman JC
Naunyn Schmiedebergs Arch Pharmacol; 1985 Dec; 331(4):364-8. PubMed ID: 2419771
[TBL] [Abstract][Full Text] [Related]
35. Basic characteristics of human lung mast cell desensitization.
MacGlashan D; Lichtenstein LM
J Immunol; 1987 Jul; 139(2):501-5. PubMed ID: 2439588
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation.
Pearce FL; Kassessinoff TA; Liu WL
Int Arch Allergy Appl Immunol; 1989; 88(1-2):129-31. PubMed ID: 2468610
[TBL] [Abstract][Full Text] [Related]
37. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
38. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
39. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
[TBL] [Abstract][Full Text] [Related]
40. Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation.
Church MK; Okayama Y; el-Lati S
Skin Pharmacol; 1991; 4 Suppl 1():15-24. PubMed ID: 1722414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
